ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,861Medicare Part D Prescriptions Filled, Including Refills

Rank: 124 out of 324

$507K Total Retail Price of All Prescriptions

Rank: 102 out of 324

245 Patients Receiving at Least One Drug in Part D
73%Patients 65 Years and Older
32% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kansas
Lower avg

Schedule Two
Controlled Substances

13% of this provider’s 245 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

17% of this provider’s 245 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

2% of this provider’s 5,267 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$64 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kansas
LEVOTHYROXINE SODIUM 377 255 1 2
SIMVASTATIN 366 241 2 1
OMEPRAZOLE 284 166 3 6
ZOLPIDEM TARTRATE 224 173 4 20
HYDROCODONE-ACETAMINOPHEN 183 81 S3 5 5
METFORMIN HCL ER 153 96 6 74
SPIRONOLACTONE 153 114 6 47
LISINOPRIL 147 130 8 3
FUROSEMIDE 144 83 9 7
CITALOPRAM HBR 117 99 10 16
ATORVASTATIN CALCIUM 117 91 10 12
AMLODIPINE BESYLATE 110 96 12 4
METOPROLOL TARTRATE 100 87 13 14
FLUTICASONE PROPIONATE 98 71 14 32
POTASSIUM CHLORIDE 93 37 15 8
ATENOLOL 89 73 16 18
ENALAPRIL MALEATE 85 69 17 57
CEFDINIR 81 52 18 260
WARFARIN SODIUM 80 66 19 10
CRESTOR 78 63 20 28
TRIAMTERENE-HCTZ 72 59 21 46
TRAZODONE HCL 70 39 22 42
MELOXICAM 69 68 23 29
ADVAIR DISKUS 68 54 24 61
GABAPENTIN 68 38 24 13
CARVEDILOL 65 42 26 22
LISINOPRIL-HYDROCHLOROTHIAZIDE 65 51 26 35
ALLOPURINOL 64 61 28 27
TAMSULOSIN HCL 62 62 29 26
HYDROCHLOROTHIAZIDE 61 46 30 11
LEVOFLOXACIN 61 39 30 84
LOVASTATIN 59 49 32 43
SINGULAIR 57 19 33 92
SPIRIVA 55 51 34 70
DIGOXIN 55 29 34 40
ACTOS 52 42 36 131
NAMENDA 52 42 36 31
NEXIUM 51 0 38 33
TRAMADOL HCL 51 35 38 19
ISOSORBIDE MONONITRATE ER 50 50 40 65
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 24, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.